Gritstone Bio

Gritstone Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and more recently extended our programs to include viral antigens displayed on the surface of virus-infected cells. The biology underlying immune system recognition of targets on the surface of abnormal cells is common to both anti-tumor and anti-viral immunity. Consequently, we believe that activating and directing the immune system to these targets could offer an important opportunity to extend the benefits of immunotherapy for more patients.
Looking for a particular Gritstone Bio employee's phone or email?

Gritstone Bio Questions

News

Gritstone bio Announces Strengthening of Maturing Phase 2 - GlobeNewswire

Gritstone bio Announces Strengthening of Maturing Phase 2 GlobeNewswire

Gritstone bio Completes Reorganization Post-Bankruptcy - TipRanks

Gritstone bio Completes Reorganization Post-Bankruptcy TipRanks

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure - Business Wire

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure Business Wire

Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer - Yahoo Finance

Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer Yahoo Finance

Gritstone files for bankruptcy in hope of keeping cancer vaccine R&D afloat - Fierce Biotech

Gritstone files for bankruptcy in hope of keeping cancer vaccine R&D afloat Fierce Biotech

Gritstone bio to Participate in Upcoming Investor Conferences - Stock Titan

Gritstone bio to Participate in Upcoming Investor Conferences Stock Titan

Gritstone bio wins $433 million US contract for COVID vaccine study - Reuters

Gritstone bio wins $433 million US contract for COVID vaccine study Reuters

Neoantigen-Directed GRANITE Immunotherapy Improves PFS as Maintenance in MSS mCRC - OncLive

Neoantigen-Directed GRANITE Immunotherapy Improves PFS as Maintenance in MSS mCRC OncLive

Gritstone bio and CEPI expand vaccine agreement to tackle Omicron variant - CEPI

Gritstone bio and CEPI expand vaccine agreement to tackle Omicron variant CEPI

Gritstone Bio says personalized cancer vaccine falls short in key trial - statnews.com

Gritstone Bio says personalized cancer vaccine falls short in key trial statnews.com

Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024 - Yahoo Finance

Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024 Yahoo Finance

Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellit - GlobeNewswire

Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellit GlobeNewswire

Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting - Stock Titan

Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting Stock Titan

CEPI enters into funding agreement with Gritstone bio to develop COVID-19 variant vaccine - CEPI

CEPI enters into funding agreement with Gritstone bio to develop COVID-19 variant vaccine CEPI

Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors - Yahoo Finance

Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors Yahoo Finance

Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering - GlobeNewswire

Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering GlobeNewswire

Gritstone bio Announces Presentations on Neoantigen - GlobeNewswire

Gritstone bio Announces Presentations on Neoantigen GlobeNewswire

Gritstone Announces First Patient Enrolled for Phase 2/3 - GlobeNewswire

Gritstone Announces First Patient Enrolled for Phase 2/3 GlobeNewswire

Leader of failed biotech urges others to hire colleagues - The Business Journals

Leader of failed biotech urges others to hire colleagues The Business Journals

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering (NASDAQ:GRTS) - Seeking Alpha

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering (NASDAQ:GRTS) Seeking Alpha

Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication - Clinical Trials Arena

Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication Clinical Trials Arena

Gritstone bio announces layoffs and Nasdaq delisting - Investing.com

Gritstone bio announces layoffs and Nasdaq delisting Investing.com

Gritstone bio secures contract for Phase IIb Covid-19 vaccine trial - Clinical Trials Arena

Gritstone bio secures contract for Phase IIb Covid-19 vaccine trial Clinical Trials Arena

Gritstone bio files monthly operating report amid Chapter 11 - Investing.com

Gritstone bio files monthly operating report amid Chapter 11 Investing.com

Gritstone bio assets auctioned for $21.25 million - Investing.com

Gritstone bio assets auctioned for $21.25 million Investing.com

GRANITE Plus ICIs and Bevacizumab/Chemo Shows Improved PFS Trend in MSS mCRC - OncLive

GRANITE Plus ICIs and Bevacizumab/Chemo Shows Improved PFS Trend in MSS mCRC OncLive

Gritstone bio (GRTSQ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Gritstone bio (GRTSQ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now Yahoo Finance

A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys - statnews.com

A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys statnews.com

Gritstone bio completes asset sale amid bankruptcy - Investing.com

Gritstone bio completes asset sale amid bankruptcy Investing.com

Gritstone bio Files for Chapter 11 Bankruptcy - Nasdaq

Gritstone bio Files for Chapter 11 Bankruptcy Nasdaq

Gritstone Bio Files for Bankruptcy and Auctions Assets - Nasdaq

Gritstone Bio Files for Bankruptcy and Auctions Assets Nasdaq

Gritstone Bio sets sale of assets through Bankruptcy Court - The Business Journals

Gritstone Bio sets sale of assets through Bankruptcy Court The Business Journals

National Cancer Institute and Gritstone bio team up on vaccine - PharmaTimes

National Cancer Institute and Gritstone bio team up on vaccine PharmaTimes

Gritstone bio announces SLATE-KRAS vaccine - Investing.com

Gritstone bio announces SLATE-KRAS vaccine Investing.com

Gritstone Files for Bankruptcy in Effort to Save Clinical Research - BioSpace

Gritstone Files for Bankruptcy in Effort to Save Clinical Research BioSpace

Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna - Bloomberg

Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna Bloomberg

Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm - PR Newswire

Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire

Gritstone bio plans move to One Kenmore Square - The Business Journals

Gritstone bio plans move to One Kenmore Square The Business Journals

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gritstone bio, - GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gritstone bio, GlobeNewswire

Down -63.39% in 4 Weeks, Here's Why Gritstone bio (GRTS) Looks Ripe for a Turnaround - Nasdaq

Down -63.39% in 4 Weeks, Here's Why Gritstone bio (GRTS) Looks Ripe for a Turnaround Nasdaq

Influential Women 2022: Celia Economides of Gritstone bio Inc. - The Business Journals

Influential Women 2022: Celia Economides of Gritstone bio Inc. The Business Journals

Top Gritstone Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant